Developing Next-Gen Inhaler Device

Novartis www.novartis.com is collaborating with Qualcomm Life www.qualcommlife.com to develop the next generation Breezhaler inhaler™ device to treat COPD. Qualcomm will provide the technology solution to provide connectivity for the device that is scheduled to be used for the Novartis portfolio for COPD treatments. Novartis plans to launch the next generation connected Breezhaler in 2019 following manufacturing, testing and regulatory approvals. …Continue reading